The global Solid Tumor Therapeutics market was valued at USD 222.71 billion in 2023 and growing at a CAGR of 14.80% from 2024 to 2033. The market is expected to reach USD 885.44 billion by 2033. Increasing investments of Pharmaceutical companies in R&D and the global rise in the number of cancer patients are the major driving factors propelling the growth of the Solid Tumor Therapeutics Market Whereas, rising government initiatives towards cancer cases and rising numbers of active market players may also provide lucrative opportunities for the growth of the Solid Tumor Therapeutics Market.
Solid Tumor Therapeutics is the type of medical treatment used to treat solid tumors which are found in different types of body parts. These types of cancers range from, Lung, prostate, Breast, Cervical cancer, and others.
The market is bifurcated among various drug types, ranging from Carboplatin, Cisplatin, Gemcitabine, Paclitaxel, Doxorubicin, and others. The rising number of cancer patients has propelled the growth of the Solid Tumor Therapeutics Market. For instance: According to the European Breast Cancer Coalition 2022 report. Every 1 in 11 women develop breast cancer before the age of 74.
Get an overview of this study by requesting a free sample
Increasing investments of pharmaceutical companies in Research & Development - A huge chunk of pharmaceutical companies continue to make significant contributions to the development of experimental drugs and technologies. The pharmaceutical sector, for instance, is significantly invested in research and development. Pharmaceutical firms invest in future research to bring high-quality, pharmaceuticals to the marketplace. Major pharma firms are boosting their R&D efficiency by investing heavily in R&D, to ensure long returns on investments, as well as by collaborating with the R&D centers worldwide. for instance: According to Statista, Roche is expected to be the world’s largest company which is investing heavily in R&D, that is, USD 14 Billion followed by Johnson & Johnson (USD 12.2 Billion), Merck & Co (USD 11.4 Billion), Pfizer (USD 10.5 Billion) and Novartis (USD 10 Billion), by the year 2026.
Increasing operation cost and the price to cure cancer- Tremendous involvement of operation cost to cure the tumor is one major restraint that may hamper the growth of the Solid Tumor Therapeutics Market. With higher prices involved with curing tumor cells, patients get limited access to high-quality treatment for cancer.
Rising government initiatives towards cancer cases – Governments across various countries have taken active measures to spread awareness about treating cancer. For instance, the Indian government has started raising about treating cancer cases not only over offline media (boards, hoardings, In-store advertisements, In-mall activations) but also over online channels (Social media channels, TV, radio, and others).
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global Solid Tumor Therapeutics market, accounting for 44% of the total market share globally. Primarily owing to the increasing number of cancer cases and established numbers of healthcare and private clinics/hospitals in the region. Whereas, Asia-Pacific is the fastest-growing region, after North America, owing to increasing Research & Development centers in the region.
Asia Pacific Region Solid Tumor Therapeutics Market Share in 2023 - 23%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
Prostate cancer has dominated the Solid Tumor Therapeutics Market, thereby capturing the market share of 47% in the Global Solid Tumor Therapeutics Market, in the year 2023. Owing to the rising number of solid tumors in males and Prostate cancer, Breast Cancer is the fastest-growing segment in the market, thereby registering the fastest growth of 17.5% in the market. Owing to the rapidly increasing number of breast cancer patients and an increasing number of market players in the market.
Bevacizumab has dominated the market owing to the increasing number of cancer patients in the market, and the increasing need to lower the growth of cancer cells in the market. Whereas, Carboplatin has witnessed the fastest growth rate in the market. Owing to the increase in side effects of cancer in the market.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2023 | USD 222.71 Billion |
Market size value in 2033 | USD 885.44 Billion |
CAGR (2024 to 2033) | 14.80% |
Historical data | 2020-2022 |
Base Year | 2023 |
Forecast | 2024-2033 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | Cancer Type, Drug Type |
As per The Brainy Insights, the size of the solid tumor therapeutics market was valued at USD 222.71 billion in 2023 to USD 885.44 billion by 2033.
The global Solid Tumor Therapeutics market is growing at a CAGR of 14.80% during the forecast period 2024-2033.
The Asia Pacific region emerged as the largest market for the solid tumor therapeutics.
The increasing investments of pharmaceutical companies in research & development will influence the market's growth.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Cancer Type
4.3.2. Market Attractiveness Analysis by Drug Type
4.3.3. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing investments of Pharmaceutical companies in R&D
5.2.2. Global rise in the number of cancer patients
5.3. Restraints
5.3.1. Increasing operational costs
5.4. Opportunities
5.4.1. Rising government initiatives towards cancer cases
5.4.2. Rising numbers of active market players
5.5. Challenges
5.5.1. Side effects associated with solid tumor therapeutics in the market
6. Global Solid Tumor Therapeutics Market Analysis and Forecast, By Cancer Type
6.1. Segment Overview
6.2. Breast Cancer
6.3. Lung Cancer
6.4. Colorectal Cancer
6.5. Prostate Cancer
6.6. Cervical Cancer
6.7. Other Cancer Types
7. Global Solid Tumor Therapeutics Market Analysis and Forecast, By Drug Type
7.1. Segment Overview
7.2. Carboplatin
7.3. Cisplatin
7.4. Gemcitabine
7.5. Paclitaxel
7.6. Doxorubicin
7.7. Bevacizumab
7.8. Erlotinib
7.9. Sunitinib
7.10. Everolimusa
7.11. Other Drug Types
8. Global Solid Tumor Therapeutics Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Solid Tumor Therapeutics Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Solid Tumor Therapeutics Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1.1. Abbott Laboratories Inc
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Amgen Inc
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Astra Zeneca PLC
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Baxter International Inc
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Biogen Inc
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Boehringer Ingelheim GmbH
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Bristol-Myers Squibb Company
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Eli Lilly and Company
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. F. Hoffmann-La Roche AG
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. GlaxoSmithKline PLC
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
2. Global Breast Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
3. Global Lung Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
4. Global Colorectal Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
5. Global Prostate Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
6. Global Cervical Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
7. Global Other Cancer Types Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
8. Global Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
9. Global Carboplatin, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
10. Global Cisplatin, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
11. Global Gemcitabine, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
12. Global Paclitaxel, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
13. Global Doxorubicin, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
14. Global Bevacizumab, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
15. Global Erlotinib, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
16. Global Sunitinib, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
17. Global Everolimusa, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
18. Global Other Drug Types, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)
19. North America Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
20. North America Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
21. U.S. Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
22. U.S. Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
23. Canada Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
24. Canada Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
25. Mexico Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
26. Mexico Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
27. Europe Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
28. Europe Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
29. Germany Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
30. Germany Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
31. France Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
32. France Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
33. U.K. Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
34. U.K. Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
35. Italy Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
36. Italy Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
37. Spain Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
38. Spain Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
39. Asia Pacific Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
40. Asia Pacific Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
41. Japan Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
42. Japan Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
43. China Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
44. China Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
45. India Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
46. India Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
47. South America Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
48. South America Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
49. Brazil Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
50. Brazil Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
51. Middle East and Africa Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
52. Middle East and Africa Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
53. UAE Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
54. UAE Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
55. South Africa Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)
56. South Africa Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)
List of Figures
1. Global Solid Tumor Therapeutics Market Segmentation
2. Global Solid Tumor Therapeutics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Solid Tumor Therapeutics Market Attractiveness Analysis by Cancer Type
9. Global Solid Tumor Therapeutics Market Attractiveness Analysis by Drug Type
10. Global Solid Tumor Therapeutics Market Attractiveness Analysis by Region
11. Global Solid Tumor Therapeutics Market: Dynamics
12. Global Solid Tumor Therapeutics Market Share by Cancer Type (2024 & 2033)
13. Global Solid Tumor Therapeutics Market Share by Drug Type (2024 & 2033)
14. Global Solid Tumor Therapeutics Market Share by Regions (2024 & 2033)
15. Global Solid Tumor Therapeutics Market Share by Company (2023)
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global solid tumor therapeutics market based on below-mentioned segments:
Global Solid Tumor Therapeutics Market by Cancer Type:
Global Solid Tumor Therapeutics Market by Drug Type:
Global Solid Tumor Therapeutics Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date